nodes	percent_of_prediction	percent_of_DWPC	metapath
Piroxicam—PTGS2—amyotrophic lateral sclerosis	0.976	1	CbGaD
Piroxicam—Lornoxicam—PTGS2—amyotrophic lateral sclerosis	0.00371	0.396	CrCbGaD
Piroxicam—Tenoxicam—PTGS2—amyotrophic lateral sclerosis	0.00331	0.353	CrCbGaD
Piroxicam—Meloxicam—PTGS2—amyotrophic lateral sclerosis	0.00236	0.251	CrCbGaD
Piroxicam—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.000445	0.0308	CbGpPWpGaD
Piroxicam—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.000362	0.0251	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.000337	0.0234	CbGpPWpGaD
Piroxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—RAB5A—amyotrophic lateral sclerosis	0.00033	0.0229	CbGpPWpGaD
Piroxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.000326	0.0226	CbGpPWpGaD
Piroxicam—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00027	0.0188	CbGpPWpGaD
Piroxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000241	0.0167	CbGpPWpGaD
Piroxicam—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000206	0.0143	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000206	0.0143	CbGpPWpGaD
Piroxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—amyotrophic lateral sclerosis	0.000205	0.0142	CbGpPWpGaD
Piroxicam—PTGS1—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.000197	0.0137	CbGpPWpGaD
Piroxicam—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.000182	0.0126	CbGpPWpGaD
Piroxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—amyotrophic lateral sclerosis	0.000181	0.0125	CbGpPWpGaD
Piroxicam—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000172	0.0119	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000163	0.0113	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000162	0.0113	CbGpPWpGaD
Piroxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—amyotrophic lateral sclerosis	0.000161	0.0112	CbGpPWpGaD
Piroxicam—PTGS1—Overview of nanoparticle effects—PTGS2—amyotrophic lateral sclerosis	0.00016	0.0111	CbGpPWpGaD
Piroxicam—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.000157	0.0109	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.000148	0.0103	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.000141	0.0098	CbGpPWpGaD
Piroxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	0.000139	0.00961	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000138	0.00957	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.000133	0.00926	CbGpPWpGaD
Piroxicam—PTGS1—Eicosanoid Synthesis—PTGS2—amyotrophic lateral sclerosis	0.000133	0.00923	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000132	0.00917	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.000132	0.00913	CbGpPWpGaD
Piroxicam—PTGS1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000131	0.0091	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000128	0.00887	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.000127	0.00882	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000124	0.00858	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000123	0.00853	CbGpPWpGaD
Piroxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	0.000115	0.00799	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000112	0.00777	CbGpPWpGaD
Piroxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.000111	0.00772	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000107	0.00745	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000106	0.00736	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000105	0.0073	CbGpPWpGaD
Piroxicam—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000104	0.00724	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.000104	0.00723	CbGpPWpGaD
Piroxicam—PTGS2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000104	0.00723	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000103	0.00716	CbGpPWpGaD
Piroxicam—PTGS2—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	0.0001	0.00696	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	9.75e-05	0.00677	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	9.37e-05	0.0065	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	9.31e-05	0.00646	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	9.25e-05	0.00642	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	9.14e-05	0.00634	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	9.13e-05	0.00634	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	8.78e-05	0.00609	CbGpPWpGaD
Piroxicam—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.47e-05	0.00588	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	8.36e-05	0.0058	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.24e-05	0.00572	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	8.14e-05	0.00565	CbGpPWpGaD
Piroxicam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	8.13e-05	0.00564	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	7.82e-05	0.00543	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	7.77e-05	0.00539	CbGpPWpGaD
Piroxicam—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	7.67e-05	0.00532	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	7.52e-05	0.00522	CbGpPWpGaD
Piroxicam—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	7.4e-05	0.00513	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	7.39e-05	0.00513	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.31e-05	0.00507	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	7.26e-05	0.00504	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.01e-05	0.00486	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.01e-05	0.00486	CbGpPWpGaD
Piroxicam—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	6.93e-05	0.00481	CbGpPWpGaD
Piroxicam—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.9e-05	0.00479	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	6.82e-05	0.00474	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	6.64e-05	0.00461	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	6.57e-05	0.00456	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	6.45e-05	0.00448	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.29e-05	0.00436	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	6.28e-05	0.00436	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.25e-05	0.00433	CbGpPWpGaD
Piroxicam—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.24e-05	0.00433	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	6.17e-05	0.00428	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	6.15e-05	0.00426	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	6.09e-05	0.00423	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	5.98e-05	0.00415	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	5.92e-05	0.00411	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.91e-05	0.0041	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.87e-05	0.00407	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.8e-05	0.00403	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	5.73e-05	0.00398	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	5.49e-05	0.00381	CbGpPWpGaD
Piroxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	5.45e-05	0.00378	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.4e-05	0.00375	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.37e-05	0.00373	CbGpPWpGaD
Piroxicam—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	5.37e-05	0.00372	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.34e-05	0.00371	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.34e-05	0.00371	CbGpPWpGaD
Piroxicam—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.31e-05	0.00369	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.25e-05	0.00364	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.02e-05	0.00348	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.01e-05	0.00348	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.99e-05	0.00346	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	4.94e-05	0.00343	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	4.89e-05	0.00339	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.81e-05	0.00334	CbGpPWpGaD
Piroxicam—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.78e-05	0.00332	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.76e-05	0.00331	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.72e-05	0.00328	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	4.71e-05	0.00327	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.69e-05	0.00326	CbGpPWpGaD
Piroxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	4.65e-05	0.00323	CbGpPWpGaD
Piroxicam—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	4.56e-05	0.00317	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.46e-05	0.0031	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.46e-05	0.0031	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	4.43e-05	0.00307	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.4e-05	0.00305	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	4.23e-05	0.00294	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.09e-05	0.00284	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.07e-05	0.00283	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.07e-05	0.00283	CbGpPWpGaD
Piroxicam—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	4.07e-05	0.00282	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.98e-05	0.00276	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.98e-05	0.00276	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	3.93e-05	0.00273	CbGpPWpGaD
Piroxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.89e-05	0.0027	CbGpPWpGaD
Piroxicam—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	3.86e-05	0.00268	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.84e-05	0.00267	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.8e-05	0.00263	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	3.75e-05	0.0026	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3.73e-05	0.00259	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.72e-05	0.00258	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	3.56e-05	0.00247	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.46e-05	0.0024	CbGpPWpGaD
Piroxicam—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.43e-05	0.00238	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	3.39e-05	0.00235	CbGpPWpGaD
Piroxicam—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.39e-05	0.00235	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.26e-05	0.00226	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.24e-05	0.00225	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.23e-05	0.00224	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.23e-05	0.00224	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.22e-05	0.00223	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	3.15e-05	0.00219	CbGpPWpGaD
Piroxicam—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	3.09e-05	0.00214	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	3.05e-05	0.00212	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	3.02e-05	0.0021	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.01e-05	0.00209	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.96e-05	0.00205	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	2.94e-05	0.00204	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	2.86e-05	0.00199	CbGpPWpGaD
Piroxicam—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.79e-05	0.00194	CbGpPWpGaD
Piroxicam—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.76e-05	0.00191	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.75e-05	0.00191	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	2.74e-05	0.0019	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.73e-05	0.00189	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.63e-05	0.00183	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	2.63e-05	0.00183	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	2.63e-05	0.00183	CbGpPWpGaD
Piroxicam—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	2.62e-05	0.00181	CbGpPWpGaD
Piroxicam—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	2.62e-05	0.00181	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	2.59e-05	0.0018	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.58e-05	0.00179	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	2.57e-05	0.00178	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	2.57e-05	0.00178	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.45e-05	0.0017	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	2.45e-05	0.0017	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.44e-05	0.00169	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.42e-05	0.00168	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	2.41e-05	0.00167	CbGpPWpGaD
Piroxicam—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	2.39e-05	0.00166	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	2.34e-05	0.00162	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	2.34e-05	0.00162	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.32e-05	0.00161	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.32e-05	0.00161	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	2.26e-05	0.00157	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.24e-05	0.00155	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.23e-05	0.00155	CbGpPWpGaD
Piroxicam—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.22e-05	0.00154	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.14e-05	0.00149	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.14e-05	0.00149	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	2.11e-05	0.00147	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.1e-05	0.00146	CbGpPWpGaD
Piroxicam—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	2.09e-05	0.00145	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.07e-05	0.00143	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	2.06e-05	0.00143	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2e-05	0.00138	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.96e-05	0.00136	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	1.9e-05	0.00132	CbGpPWpGaD
Piroxicam—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	1.89e-05	0.00131	CbGpPWpGaD
Piroxicam—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	1.88e-05	0.00131	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.88e-05	0.0013	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.87e-05	0.00129	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.82e-05	0.00126	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.77e-05	0.00123	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	1.76e-05	0.00122	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	1.74e-05	0.00121	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.71e-05	0.00119	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.69e-05	0.00117	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	1.63e-05	0.00113	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.58e-05	0.0011	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.55e-05	0.00107	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.54e-05	0.00107	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.49e-05	0.00103	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	1.47e-05	0.00102	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.44e-05	0.001	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	1.43e-05	0.000994	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	1.35e-05	0.000939	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.34e-05	0.000931	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.33e-05	0.000923	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	1.32e-05	0.000918	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	1.32e-05	0.000918	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.22e-05	0.00085	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.21e-05	0.00084	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.2e-05	0.000836	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.2e-05	0.00083	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.17e-05	0.000814	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	1.14e-05	0.000791	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.09e-05	0.000758	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	1.09e-05	0.000754	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.08e-05	0.000751	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.06e-05	0.000734	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.97e-06	0.000692	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.91e-06	0.000688	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.86e-06	0.000684	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	9.84e-06	0.000683	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.09e-06	0.000631	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	8.99e-06	0.000624	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	8.89e-06	0.000617	CbGpPWpGaD
Piroxicam—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	8.42e-06	0.000584	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.35e-06	0.000579	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.11e-06	0.000563	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.21e-06	0.000501	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	6.87e-06	0.000477	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.83e-06	0.000474	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.79e-06	0.000471	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.63e-06	0.00046	CbGpPWpGaD
Piroxicam—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	6.51e-06	0.000452	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	5.87e-06	0.000408	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.87e-06	0.000407	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.84e-06	0.000405	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.56e-06	0.000386	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	5.45e-06	0.000378	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.39e-06	0.000374	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.36e-06	0.000372	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.78e-06	0.000331	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.71e-06	0.000327	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	4.44e-06	0.000308	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	4.44e-06	0.000308	CbGpPWpGaD
Piroxicam—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	4.41e-06	0.000306	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.39e-06	0.000305	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.61e-06	0.000251	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.04e-06	0.000211	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.02e-06	0.00021	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.47e-06	0.000172	CbGpPWpGaD
